(Q52800940)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

title

Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

0 references

1 reference

1 reference

1 reference

Noureldien H E Darwish

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Shaker A Mousa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

author name string

Thangirala Sudha

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Dhruba J Bharali

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Murat Yalcin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Melis Debreli Coskun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Kelly A Keating

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Hung-Yun Lin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Paul J Davis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

publication date

19 January 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

page(s)

195-205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

Platinum-based drugs: past, present and future

9 April 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Pharmacogenomics of fluorouracil -based chemotherapy toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

An overview of doxorubicin formulations in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Advancement in integrin facilitated drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Engineered Peptides for Applications in Cancer Targeted Drug Delivery and Tumor Detection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Advances in silica based nanoparticles for targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Targeting and delivery of platinum-based anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Current advances in research and clinical applications of PLGA-based nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Integrins in cancer: biological implications and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Integrin and growth factor receptor alliance in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Spectrophotometric determination of platinum with o-phenylenediamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Anthracycline Drugs on Modified Surface of Quercetin-Loaded Polymer Nanoparticles: A Dual Drug Delivery Model for Cancer Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Protective role of naringin against cisplatin induced oxidative stress, inflammatory response and apoptosis in rat striatum via suppressing ROS-mediated NF-κB and P53 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Evaluation of multi-neuroprotective effects of erythropoietin using cisplatin induced peripheral neurotoxicity model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

Development and Validation of a Simple and Sensitive Spectrometric Method for Estimation of Cisplatin Hydrochloride in Tablet Dosage Forms: Application to Dissolution Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2016-0315

21 January 2018

Identifiers

DOI

10.2217/NNM-2016-0315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28102776%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference